SCHEMBL3787218

SCHEMBL3787218

CC(=O)SOc1cccc(-c2ccccc2N)c1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
BRD4 O60885 2/20 0.36
PTGS1 P23219 2/20 0.35
ADRA2B P18089 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
LMNA P02545 3/20 0.34
MAPT P10636 3/20 0.34
GAA P10253 2/20 0.34
HSD17B10 Q99714 3/20 0.34
CFTR P13569 1/20 0.34
RAB9A P51151 3/20 0.33
HTT P42858 1/20 0.33
TSHR P16473 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
PTGS2 P35354 1/20 0.33
NPC1 O15118 2/20 0.32
MAPK3 P27361 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3794925 0.90 ALDH1A1 (0.43) ALDH1A1L3MBTL1BRD4PTGS1ADRA2B
SCHEMBL3783966 0.86 ADORA2A (0.38) ALDH1A1L3MBTL1BRD4PTGS1ADRA2B
SCHEMBL3790313 0.84 NCOA1 (0.41) ALDH1A1L3MBTL1TDP1MEN1KMT2A
SCHEMBL3791040 0.83 ALDH1A1 (0.42) ALDH1A1L3MBTL1BRD4MEN1KMT2A
SCHEMBL3790311 0.82 PTGS2 (0.47) ALDH1A1L3MBTL1PTGS1TDP1MEN1
SCHEMBL3793489 0.82 ALDH1A1 (0.38) ALDH1A1L3MBTL1BRD4TDP1MEN1
SCHEMBL3780727 0.82 PTGDR2 (0.40) ALDH1A1L3MBTL1BRD4TDP1MEN1
SCHEMBL3794457 0.81 NCOA1 (0.38) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL3785607 0.79 MAP4K4 (0.40) ALDH1A1L3MBTL1BRD4ADRA2BMAPT
SCHEMBL3784752 0.78 ALDH1A1 (0.38) ALDH1A1L3MBTL1BRD4TDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 ALDH1A1 4339/4885L3MBTL1 3838/4885BRD4 96/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.